SE0302029D0 - Novel process - Google Patents

Novel process

Info

Publication number
SE0302029D0
SE0302029D0 SE0302029A SE0302029A SE0302029D0 SE 0302029 D0 SE0302029 D0 SE 0302029D0 SE 0302029 A SE0302029 A SE 0302029A SE 0302029 A SE0302029 A SE 0302029A SE 0302029 D0 SE0302029 D0 SE 0302029D0
Authority
SE
Sweden
Prior art keywords
novel process
production
size distribution
relates
high yield
Prior art date
Application number
SE0302029A
Other languages
English (en)
Swedish (sv)
Inventor
Philippe Rogueda
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0302029A priority Critical patent/SE0302029D0/xx
Publication of SE0302029D0 publication Critical patent/SE0302029D0/xx
Priority to JP2006518339A priority patent/JP2007527381A/ja
Priority to AU2004255517A priority patent/AU2004255517A1/en
Priority to PCT/GB2004/002882 priority patent/WO2005004847A1/en
Priority to KR1020067000285A priority patent/KR20060052779A/ko
Priority to US10/563,685 priority patent/US20060188579A1/en
Priority to CNA2004800196007A priority patent/CN1819818A/zh
Priority to MXPA05014075A priority patent/MXPA05014075A/es
Priority to EP04743228A priority patent/EP1648414A1/en
Priority to CA002531025A priority patent/CA2531025A1/en
Priority to BRPI0412445-6A priority patent/BRPI0412445A/pt
Priority to IL172771A priority patent/IL172771A0/en
Priority to ZA200600110A priority patent/ZA200600110B/en
Priority to NO20060607A priority patent/NO20060607L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B01D9/005—Selection of auxiliary, e.g. for control of crystallisation nuclei, of crystal growth, of adherence to walls; Arrangements for introduction thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B01D9/005—Selection of auxiliary, e.g. for control of crystallisation nuclei, of crystal growth, of adherence to walls; Arrangements for introduction thereof
    • B01D9/0054—Use of anti-solvent
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B01D9/0063—Control or regulation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B01D9/0081—Use of vibrations, e.g. ultrasound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Medicinal Preparation (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Silicon Compounds (AREA)
SE0302029A 2003-07-07 2003-07-07 Novel process SE0302029D0 (sv)

Priority Applications (14)

Application Number Priority Date Filing Date Title
SE0302029A SE0302029D0 (sv) 2003-07-07 2003-07-07 Novel process
BRPI0412445-6A BRPI0412445A (pt) 2003-07-07 2004-07-05 processo para preparação de partìculas cristalinas de tamanho mìcron, usando um solvente, um não-solvente e energia ultra-sÈnica
CNA2004800196007A CN1819818A (zh) 2003-07-07 2004-07-05 新方法
AU2004255517A AU2004255517A1 (en) 2003-07-07 2004-07-05 Novel process
PCT/GB2004/002882 WO2005004847A1 (en) 2003-07-07 2004-07-05 Novel process
KR1020067000285A KR20060052779A (ko) 2003-07-07 2004-07-05 신규 방법
US10/563,685 US20060188579A1 (en) 2003-07-07 2004-07-05 Novel process
JP2006518339A JP2007527381A (ja) 2003-07-07 2004-07-05 溶媒、非溶媒および超音波エネルギーを用いるミクロン−サイズの結晶性粒子の作製のための加工法
MXPA05014075A MXPA05014075A (es) 2003-07-07 2004-07-05 Proceso para preparar particulas cristalinas de tamano de micras que usa un solvente, un no solvente y energia ultrasonica.
EP04743228A EP1648414A1 (en) 2003-07-07 2004-07-05 Process for the preparation of micron-size crystalline particles using a solvent, a non-solvent and ultrasonic energy
CA002531025A CA2531025A1 (en) 2003-07-07 2004-07-05 Process for the preparation of micron-size crystalline particles using a solvent, a non-solvent and ultrasonic energy
IL172771A IL172771A0 (en) 2003-07-07 2005-12-22 Process for the preparation of micron-size crystalline particles using a solvent, a non-solvent and ultrasonic energy
ZA200600110A ZA200600110B (en) 2003-07-07 2006-01-05 Novel process
NO20060607A NO20060607L (no) 2003-07-07 2006-02-07 Ny fremgangsmate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0302029A SE0302029D0 (sv) 2003-07-07 2003-07-07 Novel process

Publications (1)

Publication Number Publication Date
SE0302029D0 true SE0302029D0 (sv) 2003-07-07

Family

ID=27764955

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0302029A SE0302029D0 (sv) 2003-07-07 2003-07-07 Novel process

Country Status (14)

Country Link
US (1) US20060188579A1 (no)
EP (1) EP1648414A1 (no)
JP (1) JP2007527381A (no)
KR (1) KR20060052779A (no)
CN (1) CN1819818A (no)
AU (1) AU2004255517A1 (no)
BR (1) BRPI0412445A (no)
CA (1) CA2531025A1 (no)
IL (1) IL172771A0 (no)
MX (1) MXPA05014075A (no)
NO (1) NO20060607L (no)
SE (1) SE0302029D0 (no)
WO (1) WO2005004847A1 (no)
ZA (1) ZA200600110B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20032054A1 (it) 2003-10-22 2005-04-23 Monteres S R L Processo per la preparazione di sospensioni farmaceutiche da inalare.
AU2006270165B2 (en) * 2005-07-14 2010-03-11 Neothetics, Inc. Sustained release enhanced lipolytic formulation for regional adipose tissue treatment
PL2077830T3 (pl) * 2006-10-17 2013-04-30 Lithera Inc Sposoby, kompozycje i formulacje do leczenia orbitopatii tarczycowej
GB0806873D0 (en) * 2008-04-16 2008-05-21 Breath Ltd Steroid nebuliser formulation
ES2611031T3 (es) * 2008-07-18 2017-05-04 Prosonix Limited Proceso de mejora de la cristalinidad
US9132084B2 (en) 2009-05-27 2015-09-15 Neothetics, Inc. Methods for administration and formulations for the treatment of regional adipose tissue
KR20120113267A (ko) * 2010-01-15 2012-10-12 리쎄라 인코오포레이티드 동결건조 케이크 제제
CA2812262A1 (en) 2010-09-22 2012-03-29 Map Pharmaceuticals, Inc. Aerosol composition for administering drugs
GEP201606551B (en) 2010-11-24 2016-10-10 Novamedica Llc Selective, lipophilic, and long-acting beta agonists monotherapeutic formulations tions and methods for cosmetic treatment of adiposity and contour bulging
EP3925625A1 (en) * 2011-01-09 2021-12-22 ANP Technologies, Inc. Hydrophobic molecule-induced branched polymer aggregates and their use
CN102807585B (zh) * 2012-08-06 2015-08-12 广西田园生化股份有限公司 一种采用超声波辅助技术结晶毒氟磷的方法
CN103588846B (zh) * 2012-08-15 2016-08-03 重庆华邦制药有限公司 一种丙酸氟替卡松微粒的制备方法及其用途
WO2014137982A1 (en) 2013-03-08 2014-09-12 The Board Of Trustees Of The University Of Illinois Ultrasonic method and apparatus for producing particles having a controlled size distribution
CN109988074A (zh) * 2018-06-01 2019-07-09 药璞(上海)医药科技有限公司 一种适合药用的硫酸特布他林晶型b的制备方法
WO2022134000A1 (zh) * 2020-12-25 2022-06-30 深圳晶泰科技有限公司 连续激发结晶的方法及系统

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9501384D0 (sv) * 1995-04-13 1995-04-13 Astra Ab Process for the preparation of respirable particles
GB9828721D0 (en) * 1998-12-24 1999-02-17 Glaxo Group Ltd Novel apparatus and process
GB0016040D0 (en) * 2000-06-29 2000-08-23 Glaxo Group Ltd Novel process for preparing crystalline particles
PL364626A1 (en) * 2001-05-05 2004-12-13 Accentus Plc Formation of small crystals
GB0125604D0 (en) * 2001-10-25 2001-12-19 Glaxo Group Ltd Novel process
WO2004034943A2 (en) * 2002-10-17 2004-04-29 Boehringer Ingelheim Pharma Gmbh & Co.Kg Process and reactor for the manufacture of powders of inhalable medicaments

Also Published As

Publication number Publication date
NO20060607L (no) 2006-04-07
BRPI0412445A (pt) 2006-09-19
ZA200600110B (en) 2007-01-31
IL172771A0 (en) 2006-04-10
CN1819818A (zh) 2006-08-16
CA2531025A1 (en) 2005-01-20
WO2005004847A1 (en) 2005-01-20
US20060188579A1 (en) 2006-08-24
MXPA05014075A (es) 2006-03-02
KR20060052779A (ko) 2006-05-19
AU2004255517A1 (en) 2005-01-20
EP1648414A1 (en) 2006-04-26
JP2007527381A (ja) 2007-09-27

Similar Documents

Publication Publication Date Title
SE0302029D0 (sv) Novel process
TW200724521A (en) Process for producing ethylene
HK1088597A1 (en) Method for the production of substituted 3-aryl-butyl amine compounds
TW200508201A (en) Novel process for the preparation of roflumilast
TW200616646A (en) Synthesis of boronic ester and acid compounds
TW200728248A (en) Process for producing propylene
RS70904A (en) Process for preparing indolinone derivatives
MX2009005664A (es) D-isoglutamil-d-triptofano cristalino, y la sal monoamonica de d-isoglutamil-d-triptofano.
TW200716564A (en) Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
NO20074047L (no) Ny fremgangsmate for fremstilling av substituerte indoler
NO20056238L (no) Forbedrede mater for fremstilling av Alfa-Polymorfisk Eletriptanhydrobromid
TW200621703A (en) Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
MXPA03004986A (es) Proceso para preparar polimeros de emulsion con alta pureza.
MX2007013872A (es) Procedimiento para la produccion de 4-bifenililazetidina-2-onas.
IL200000A (en) Process for Preparing 5- (1- Alkylthio) Alkylpyridines are Stored in Position 2 and Its Compounds
ZA200800138B (en) Process for the preparation of crystalline perindopril
BR0214445B1 (pt) processos para a produção de compostos.
SG146645A1 (en) Process for the synthesis of 6-amino-4-(3-chloro-4fluoro-phenylamino)-7- ethoxy-quinoline-3-carbonitrile
EA200800466A1 (ru) Способ получения эрбумина периндоприла
IL168110A0 (en) Process for production of an acetylenic compound
AU2002358557A1 (en) Improved method for the production of biphosphites
EA200802065A1 (ru) Синтез замещённых флуоренов
AU2003271871A1 (en) Process for the production of alkenyl carboxylates
DK1646607T3 (da) Fremgangsmåde til fremstilling af krystallinsk dexloxiglumid
TW200407314A (en) Preparation of 4, 6-dichloro-5-fluoropyrimidine